Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity
{{output}}
Typically, screening collections of pharmaceutical companies contain more than a million compounds today. However, for certain high-throughput screening (HTS) campaigns, constraints posed by the assay throughput and/or the reagent costs make it impractical to ... ...
